期刊文献+

siRNA沉默EZH2表达对人膀胱癌细胞迁移和凋亡的影响 被引量:3

The effect of cell activation and apoptosis by siRNA interference EZH2 expression in human bladder cancer cells
下载PDF
导出
摘要 目的探讨小干扰RNA(siRNA)沉默EZH2表达对人膀胱癌细胞增殖、侵袭和迁移能力,以及对凋亡的影响。方法构建靶向EZH2基因的siRNA质粒并转染至人膀胱癌细胞中(干扰组),采用RT-PCR法检测EZH2mRNA的表达情况,利用噻唑蓝(MTT)、Transwell细胞小室及划痕实验检测转染后细胞增殖、侵袭和转移能力的变化,通过流式细胞术实验观察转染后细胞的凋亡情况。结果转染EZH2基因的siRNA质粒后(分干扰1组,干扰2组,干扰3组),干扰各组EZH2mRNA表达较阴性对照组有明显抑制(P<0.05),且干扰2组效果最好,因此选干扰2组作后期实验;在转染48h后,干扰2组生长抑制率达37.9%,较阴性对照组受到明显抑制(P<0.05);划痕实验处理24h后,干扰2组细胞的迁移距离较阴性对照组明显降低(P<0.01);干扰2组细胞侵袭能力较阴性对照组下降了67%,差异有统计学意义(P<0.01);转染48h后,干扰2组早、晚期凋亡率分别为22.80%和3.60%,较阴性对照组增加,且以早期明显,差异有统计学意义(P<0.01)。结论 EZH2基因沉默能有效抑制人膀胱癌细胞的增殖、侵袭和迁移能力,并促进其凋亡,为深入研究膀胱癌的基因治疗提供理论依据。 Objective To investigate the effect of EZH2 knockdown on cell proliferation ,invasion ,migration and apoptosis in hu-man bladder cancer cell line by small interfering RNAs(siRNA) .Methods The siRNA-expressing plasmid targeting EZH2 gene was constructed and transfected into T24 cells .RT-PCR was used to detect the EZH2 gene′s expression at the level of mRNA ;pro-liferation ,invasion and migration of T24 cells were examed in vivo by MTT ,wound healing assay and Transwell chamber migration assay .Finally ,Annexin V-FITC/PI flow cytometric analysis was performed for cell apoptosis .Results The siRNA-expressing plas-mid targeting EZH2 gene successfully inhibited EZH2 gene’s expression in T24 cells .The expression of mRNA was significantly inhibited compared with negative control groups (P〈0 .05) .After the transfection of the plasmid 48 hours ,the growth inhibition rate was 37 .9% ,which was higher than the negative control group(P〈0 .05) .24 hours after wound healing ,the migration distance of transfected group cell was(1 .37 ± 0 .12) ,which was lower than the negative control group(P〈0 .01) .Compared with the nega-tive control group ,invasion capability of EZH2-siRNA group was dropped by 67% (P〈0 .01) .48 hours after transfection ,the early and secondary apoptosis rate of T 24 cells were 22 .80% and 3 .60% respectively ,which were higher than the negative contral group (P〈0 .01) .Conclusion The siRNA interference EZH2 can significantly inhibit cell proliferation ,invasion and migration of T24 cells ,meanwhile promote its apoptosis .It provides a theoretical basis for further study of bladder cancer gene therapy .
出处 《重庆医学》 CAS CSCD 北大核心 2014年第20期2620-2623,共4页 Chongqing medicine
基金 云南省科技厅-昆明医科大学联合专项(2011FB202)
关键词 膀胱肿瘤 RNA 小分子干扰 EZH2基因 迁移 凋亡 bladder neoplasms RNA, small interfering EZH2 migration apoptosis
  • 相关文献

参考文献15

  • 1Ploeg M, Aben KK,Kiemeney LA. The present and future burden of urinary bladder cancer in the world[J]. World J Urol, 2009,27(3) :289-293.
  • 2Chang CJ, Hung MC. The role of EZH2 in tumour pro- gression[J]. Br J Cancer,2012,106(2) :243-247.
  • 3Zhang H, Zhao M, Lv Z, et al. MiR-138 Inhibits Tumor Growth Through Repression of EZH2 in Non-Small Cell Lung Cancer[J]. Cell Physiol Biochem, 2013,31 ( 1 ) : 56-65.
  • 4Ferraro A, Mourtzoukou D, Kosmidou V, et al. EZH2 is regulated by ERK/AKT and targets integrin alpha2 gene to control Epithelial-Mesenchymal Transition and anoikis in colon cancer cells[J]. Int J Biochem Cell Biol, 2013,45 (2) :243-254.
  • 5Ntziachristos P, Tsirigos A, Van Vlierberghe P, et al. Ge- netic inactivation of the polycomb repressive complex 2 in T cell acute lymphoblastic leukemia[J]. Nat Med, 2012, 18(2) : 298-301.
  • 6Shin YJ,Kim JH. The role of EZH2 in the regulation of the activity of matrix metalloproteinases in prostate canc- er cells[J]. PLoS One, 2012,7 ( 1 ) : e30393.
  • 7Garipov A, Li H,Bitler BG, et al. NF-YA underlies EZH2 upregulation and is essential for proliferation of human epithelial ovarian cancer cells[J]. Mol Cancer Res, 2013, 20(4) :513-520.
  • 8Sauvageau M, Sauvageau G. Polycomb group proteins:multi-faceted regulators of somatic stem cells and cancer [J]. Cell Stem Cell,2010,7(3) :299-313.
  • 9Xiao Y. Enhancer of zeste homolog 2:a potential target for tumor therapy[J]. Int J Biochem Cell Biol, 2011,43 (4) :474-477.
  • 10Takawa M, Masuda K, Kunizaki M, et al. Validation of the histone methyltransferase EZH2 as a therapeutic tar- get for various types of human cancer and as a prognostic marker[J]. Cancer Sci,2011,102(7) : 1298-1305.

同被引文献39

  • 1万远廉,戎龙,刘玉村,汪欣,吴涛,潘义生,姚宏伟,叶京明,汤坚强,朱静.组织因子对大肠癌侵袭能力的影响及其与基质金属蛋白酶-9的关系[J].中华实验外科杂志,2004,21(9):1087-1088. 被引量:17
  • 2Pacheco-Figueiredo L,Antunes L,Bento MJ,et al.Evaluation of the frequency of and survival from second primary cancers in North Portugal:apopulation-based study[J].Eur J Cancer Prev,2013,22(6):599-606.
  • 3Allchorne P,Lamb BW,Kinsella J,et al.Initial experience of intravesical gemcitabine for patients with high-risk superficial transitional cell carcinoma of the bladder following BCG failure[J].Urol Nurs,2014,34(2):95-99.
  • 4Milla P,Fiorito C,Soria F,et al.Intravesical thermo-chemotherapy based on conductive heat:a first pharmacokinetic study with mitomycin C in superficial transitional cell carcinoma patients[J].Cancer Chemother Pharmacol,2014,73(3):503-509.
  • 5Hirata T,Watanabe M,Kaku H,et al.REIC/Dkk-3-encoding adenoviral vector as a potentially effective therapeutic agent for bladder cancer[J].Int J Oncol,2012,41(2):559-564.
  • 6Kaba M,Pirincci N,Benli E,et al.Dickkopf-1levels in Turkish patients with bladder cancer and its association with clinicopathological features[J].Asian Pac J Cancer Prev,2014,15(1):381-384.
  • 7Pili R,Qin R,Flynn PJ,et al.A phaseⅡsafety and efficacy study of the vascular endothelial growth factor receptor tyrosine kinase inhibitor pazopanib in patients with metastatic urothelial cancer[J].Clin Genitourin Cancer,2013,11(4):477-483.
  • 8Laurent VM,Duperray A,Sundar Rajan V,et al.Atomic force microscopy reveals a role for endothelial cell icam-1expression in bladder cancer cell adherence[J].PLoS One,2014,9 (5):e98034.
  • 9Wieczorek E,Reszka E,Jablonowski Z,et al.Genetic polymorphisms in matrix metalloproteinases(MMPs)and tissue inhibitors of MPs(TIMPs),and bladder cancer susceptibility[J].BJU Int,2013,112(8):1207-1214.
  • 10Peng Y,Li L,Huang M,et al.Angiogenin interacts with ribonuclease inhibitor regulating PI3K/AKT/mTOR signaling pathway inbladder cancer cells[J].Cell Signal,2014,26(12):2782-2772.

引证文献3

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部